脊髓损伤后功能恢复的桥接:临床可及神经调控、神经康复与生物标志物的新兴方向
本文综述脊髓损伤(SCI)后功能恢复的策略,指出缺乏逆转神经损伤的细胞或药物疗法时,基于神经可塑性的任务导向训练仍是改善功能最有效的手段。临床可及的神经调控可影响脊髓与皮质环路以增强手部和步行功能及管理痉挛,而电生理、影像和分子生物标志物及临床预测模型有助于估计恢复潜力、指导干预选择和识别可能应答者。将密集的、神经科学告知的系统记录康复纳入临床试验方案,并用生物标志物或预测模型对参与者分层,可提高研究证据的稳健性和治疗效应检测。
要点
- 任务导向训练驱动使用依赖性神经可塑性,是SCI后改善功能最有效的手段。
- 临床可及神经调控可增强手部和步行功能并管理痉挛。
- 生物标志物和预测模型可估计恢复潜力、指导干预并识别应答者。
核心结论
- 将密集的、神经科学告知的系统记录康复纳入临床试验方案,并用生物标志物或预测模型分层参与者,可支持更靶向、高效和有影响力的SCI康复与研究。
研究设计与样本
- 本文为综述,检索范围未在原文中明确报告。
主要发现
- 临床可及神经调控可影响脊髓和皮质环路以增强手部和步行运动输出并管理痉挛。
- 新兴电生理、影像和分子生物标志物及 established 临床预测模型可估计恢复潜力、指导干预选择和识别可能应答者。
- 睡眠中记录的肢体加速度等新型生理测量提供神经运动功能的非侵入性指标,可能提高预测准确性。
关键数值与推荐
- 任务导向练习驱动使用依赖性神经可塑性和功能增益,并可通过神经调控干预增强。
- 神经调控策略须优先考虑成本效益和临床可及的工具以最大化现实影响。
- 将密集的、神经科学告知且系统记录的康复纳入临床试验方案对开发最有效SCI疗法至关重要。
- 利用预测工具减少变异性并增强统计功效可提高可重复性并优化治疗效应检测。
临床怎么用
- 优先采用任务导向训练驱动神经可塑性以改善SCI患者功能。
- 选用成本效益好、临床可及的神经调控工具增强手部和步行功能及管理痉挛。
- 利用现有临床预测模型和新兴生物标志物估计恢复潜力并指导个体化干预选择。
- 在临床研究中系统记录康复内容并用生物标志物或预测模型分层参与者。
局限性
- 临床表型异质性和反应性变异持续挑战个体化治疗规划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BackgroundSpinal cord injury (SCI) has profound and often lifelong consequences. In the absence of proven cellular or pharmacologic therapies to reverse neural damage, neurorehabilitation strategies that harness neuroplasticity through practice and training remain the most effective means of improving function. Task‑oriented practice drives use‑dependent neuroplasticity and functional gains, and can be augmented by neuromodulatory interventions. To maximize real‑world impact, neuromodulatory strategies must prioritize cost‑effective, clinically accessible tools. Obtaining the best outcomes from rehabilitation also depends on the ability to anticipate future functional potential and tailor interventions accordingly. When expertly and consistently applied, some current clinical measures provide valuable predictive insight, but heterogeneity in clinical presentation and variability in responsiveness continue to challenge individualized treatment planning.ObjectivesThis article will examine how neuromodulatory strategies, predictive measures, and biomarkers can be integrated with intensive, neuroscience-informed rehabiltation to improve functional outcomes, enhance clinical trial design, and advance individualized care for people with SCI.ResultsClinically accessible neuromodulation can influence spinal and cortical circuits to enhance motor output for improved hand and walking function and for managing spasticity. Emerging electrophysiological, imaging, and molecular biomarkers, along with established clinical prediction models offer means to estimate recovery potential, guide intervention selection, and identify likely responders. Novel physiologic measures, such as limb accelerations recorded during sleep, provide noninvasive indicators of neuromotor function that may improve prediction accuracy.ConclusionIncorporating intensive, neuroscience-informed and systematically‑documented rehabilitation into clinical trial protocols is essential for developing the most effective SCI therapies. In addition, stratifying participants using biomarker or prediction model profiles can lead to more robust research evidence. Leveraging predictive tools to reduce variability and enhance statistical power can improve reproducibility and optimize detection of treatment effects. Together, these strategies support more targeted, efficient, and impactful SCI rehabilitation and research, with the potential to deliver advances that have long eluded the field.
引用
- Field-Fote EC, Zarkou A, Evans NH, et al. Bridging the Gaps for Functional Restoration After Spinal Cord Injury: Emerging Directions in Clinically Accessible Neuromodulation, Neurorehabilitation, and Biomarkers. Neurorehabil Neural Repair. 2026. PMID: 41986252. doi:10.1177/15459683261426349
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。